Pseudomyxoma peritonei: A need to establish evidence-based standard of care-is this the right trial?

Annals of Surgical Oncology

Volumn 16, Issue 10, 2009, Pages 2675-2677

  Chua, Terence C ^a   Al Mohaimeed, Khaled ^b   Liauw, Winston ^a   Morris, David L ^a,b  

^a ST GEORGE HOSPITAL   (Australia)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; FLUOROURACIL; MITOMYCIN C;

CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); CYTOREDUCTIVE SURGERY; DRUG EFFICACY; EARLY POSTOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; EVIDENCE BASED PRACTICE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; OVERALL SURVIVAL; PERITONEUM PSEUDOMYXOMA; PROGRESSION FREE SURVIVAL; REVIEW; APPENDIX TUMOR; CLINICAL TRIAL; EDITORIAL;

APPENDICEAL NEOPLASMS; CLINICAL TRIALS AS TOPIC; HUMANS; PSEUDOMYXOMA PERITONEI;

EID: 73349125797     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0550-1     Document Type: Review

References (16)

1. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritonealmucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol. 1995;19:1390-408.
2. Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D, et al. Pseudomyxoma peritonei syndrome. Adv Surg. 1996;30:233-80.
3. Mann WJ, Wagner J, Chumas J, Chalas E. The management of pseudomyxoma peritonei. Cancer. 1990; 66:1636-40.
4. Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucin-ous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008;98:277-82.
5. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7:69-76.
6. Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2007;14:484-92.
7. Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M. Pseudomyxoma peritonei\Biological features are the domi-nant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2009;249: 243-9.
8. Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol. 2007;14: 2289-99.
9. Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, et al. Long-term survival in patients with pseudomyxoma perit-onei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol. 2009;16:1903-11.
10. Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach [see comment]. Ann Surg. 1994;219:112-9.
11. Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy [see comment]. Ann Surg. 2005;241:300-8.
12. Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. Rationale and techniques of intra-operative hyperthermic intra-peritoneal chemotherapy. Cancer Treat Rev. 2001;27:365-74.
13. Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, et al. Early postoperative intraperitoneal chemo-therapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res. 1990;50:5790-4.
14. Elias D, Benizri E, DiPietrantonio D, Menegon P, Malka D, Raynard B. Comparison of two kinds of intraperitoneal chemo-therapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2006;14:509-14.
15. Bradley RF, Steward JH, Russell GB, Levine EA, Giesinger KR. Pseudomyxoma peritonei of appendiceal origin: A clinicopatho-logic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30: 551-9.
16. Smeenk RM, Verwaal VJ, Zoetmulder FAN. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei\a report of 103 proce-dures. Eur J Surg Oncol. 2006;32:186-90.